These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20827233)

  • 1. Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype.
    Moncrieffe H; Hinks A; Ursu S; Kassoumeri L; Etheridge A; Hubank M; Martin P; Weiler T; Glass DN; Thompson SD; Thomson W; Wedderburn LR
    Pharmacogenet Genomics; 2010 Nov; 20(11):665-76. PubMed ID: 20827233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.
    Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W
    Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.
    Zajc Avramovič M; Dolžan V; Toplak N; Accetto M; Lusa L; Avčin T
    J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
    Moncrieffe H; Bennett MF; Tsoras M; Luyrink LK; Johnson AL; Xu H; Dare J; Becker ML; Prahalad S; Rosenkranz M; O'Neil KM; Nigrovic PA; Griffin TA; Lovell DJ; Grom AA; Medvedovic M; Thompson SD
    Rheumatology (Oxford); 2017 Sep; 56(9):1542-1551. PubMed ID: 28582527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis.
    Kyvsgaard N; Mikkelsen TS; Als TD; Christensen AE; Corydon TJ; Herlin T
    Pediatr Rheumatol Online J; 2021 Apr; 19(1):51. PubMed ID: 33794950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.
    Yanagimachi M; Naruto T; Hara T; Kikuchi M; Hara R; Miyamae T; Imagawa T; Mori M; Kaneko T; Morita S; Goto H; Yokota S
    Br J Clin Pharmacol; 2011 Feb; 71(2):237-43. PubMed ID: 21219404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
    van Dijkhuizen EH; Wulffraat NM
    Pediatr Rheumatol Online J; 2014; 12():51. PubMed ID: 25525416
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
    Scand J Rheumatol; 2021 May; 50(3):213-217. PubMed ID: 33025831
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study.
    Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
    Int J Rheum Dis; 2020 Nov; 23(11):1505-1513. PubMed ID: 32969158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis.
    de Rotte MC; Bulatovic M; Heijstek MW; Jansen G; Heil SG; van Schaik RH; Wulffraat NM; de Jonge R
    J Rheumatol; 2012 Oct; 39(10):2032-40. PubMed ID: 22859359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis.
    Pastore S; Stocco G; Moressa V; Zandonà L; Favretto D; Malusà N; Decorti G; Lepore L; Ventura A
    Rheumatol Int; 2015 Apr; 35(4):619-27. PubMed ID: 25240429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases.
    Cobb J; Cule E; Moncrieffe H; Hinks A; Ursu S; Patrick F; Kassoumeri L; Flynn E; Bulatović M; Wulffraat N; van Zelst B; de Jonge R; Bohm M; Dolezalova P; Hirani S; Newman S; Whitworth P; Southwood TR; De Iorio M; ; ; ; Wedderburn LR; Thomson W
    Pharmacogenomics J; 2014 Aug; 14(4):356-64. PubMed ID: 24709693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis.
    Scheuern A; Fischer N; McDonald J; Brunner HI; Haas JP; Hügle B
    Pediatr Rheumatol Online J; 2016 Feb; 14(1):11. PubMed ID: 26928923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
    Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
    Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
    Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
    Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
    Roszkiewicz J; Smolewska E
    Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
    Funk RS; Chan MA; Becker ML
    Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of the immune response mediator genes’ polymorphic variants with the methotrexate efficacy in juvenile idiopathic arthritis.
    Nazarova L; Danilko K; Malievsky V; Karimov D; Bakirov A; Viktorova T
    Turk J Med Sci; 2020 Jun; 50(4):1038-1047. PubMed ID: 31958219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis.
    Bašić J; Vojinović J; Jevtović-Stoimenov T; Despotović M; Cvetković T; Lazarević D; Sušić G; Milošević V; Cvetković M; Pavlović D
    Rheumatol Int; 2019 Mar; 39(3):551-559. PubMed ID: 30680511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.